This project explored research that involves the design and construction of novel artificial biological pathways.
Links to external sources may no longer work as intended. The content may not represent the latest thinking in this area or the Society’s current position on the topic.
Synthetic biology involves the design and construction of novel artificial biological pathways, organisms and devices or the redesign of existing natural biological systems.
It has enormous potential applications and benefits, including the development of cheap anti-malarial drugs, the production of green hydrogen for fuel and the use of programmable cells to treat cancer. There is promise, but also uncertainty about how govern this emerging field. It was the subject of President Obama's first Presidential Commission on Bioethics in the US. A special public dialogue exercise commissioned by the UK Government explored the implications for society of technological development in this area. The Royal Society is undertaking a range of work to address these issues.
In 2011 and 2012 a seiries of six academies symposia on synthetic biology were held with the Royal Academy of Engineering and the national academies of science and engineering in China and the USA.